This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04893512
Recruitment Status : Completed
First Posted : May 19, 2021
Last Update Posted : April 20, 2023
Sponsor:
Collaborator:
US Specialty Formulations, LLC
Information provided by (Responsible Party):
Syneos Health

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 11, 2022
Actual Study Completion Date : November 11, 2022